Sign In
12 Jan 2017 07:00
12 January 2017
Exova Group plc
Post-close Trading Update
Exova Group plc ("Exova"), a leading international provider of technically demanding testing, certification and advisory services, today issues the following update on trading.
The Board is pleased to report that trading for November and December 2016 was in line with its expectations and, therefore, full year guidance remains consistent with our Trading Update on 24 November 2016.
The Group's full year results to 31 December 2016 will be announced on 28 February 2017.
Contacts
Peter Ogden / Andy Jones
Powerscourt Group
Tel. Direct +44 (0)20 7549 0997 / +44 (0)7793 858 211
exova@powerscourt-group.com
Exova
Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 134 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.
Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.
This Trading Update release contains forward-looking statements that involve substantial risks and uncertainties and actual results and developments may differ materially from those expressed or implied by these statements by a variety of factors. These forward-looking statements speak only as at the date of this press release. In addition, all projections, valuations and statistical analyses provided in this document may be based on unaudited pro-forma financial information, subjective assessments and assumptions. They may use alternative methodologies that produce different results and should not be relied upon as an accurate prediction of future performance.
Follow the stocks
